Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1150360
Abstract: The progression of non-alcoholic fatty liver disease (NAFLD), the most common liver disease, leads to non-alcoholic steatohepatitis and hepatocellular carcinoma. Despite the increasing incidence and prevalence of NAFLD, its therapeutic and preventive strategies to lower… read more here.
Keywords: related hepatocellular; hepatocellular carcinoma; immunotherapy nafld; nafld related ... See more keywords